Ocular toxoplasmosis: The influence of patient age

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 2, 2009, Pages 351-357

  Holland, Gary N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age; Elderly; Eye; Recurrence; Retinochoroiditis; Toxoplasmosis

Indexed keywords

TOXOPLASMA GONDII;

EID: 65549141338     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000200031     Document Type: Article

References (52)

1. Alford CAJ, Stagno S, Reynolds DW 1974. Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull N Y Acad Med 50: 160-181.
2. Bosch-Driessen EH, Rothova A 1999. Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol 128: 421-425.
3. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A 2002. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109: 869-878.
4. Brezin AP, Thulliez P, Couvreur J, Brézin AP, Thulliez P, Couvreur J, Nobré R, Mcleod R, Mets MB 2003. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol 135: 779-784.
5. Burnett AJ, Shortt SG, Isaac-Rentom J, Burnett AJ, Shortt SG, Isaac-Renton J, King A, Werker D, Bowie WR 1998. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 105: 1032-1037.
6. Carme B, Tirard-Fleury V 1996. Toxoplasmosis among pregnant women in France: seroprevalence, seroconversion and knowledge levels. Trends 1965-1995. Med Mal Infect 26 (Suppl 3): 431-436.
7. Couvreur J, Desmonts G 1962. Congenital and maternal toxoplasmosis: a review of 300 congenital cases. Develop Med Child Neurol 4: 519-530.
8. Dadgostar H, Silveira C, Jones JL, Lee G, Muccioli C, Belfort R Jr, Holland GN 2008. Risk factors for ocular toxoplasmosis among individuals recently infected by Toxoplasma gondii in Southern Brazil. ARVO Program Book (ARVO Abstract) Program 5529, Abstract A140, Fort Lauderdale, p.356.
9. de Moura L, Bahia-Oliveira LM, Wada MY, Jones JL, Tuboi SH, Carmo EH, Ramalho WM, Camargo NJ, Trevisan R, Graça RM, da Silva AJ, Moura I, Dubey JP, Garrett DO 2006. Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis 12: 326-329.
10. Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, Ten Dam-van Loon N, Muccioli C, Hovakimyan A, Barisani-Asenbauer T, International Ocular Toxoplasmosis Research Group 2008. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol 146: 856-865.
11. Fardeau C, Romand S, Rao NA, Cassoux N, Bettembourg O, Thulliez P, Lehoang P 2002. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 134: 196-203.
12. Friedmann CT, Knox DL 1969. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 81: 481-493.
13. Garweg JG, Scherrer JN, Halberstadt M 2008. Recurrence characteristics in European patients with ocular toxoplasmosis. Br J Ophthalmol 92: 1253-1256.
14. Gilbert RE, Dunn DT, Lightman S, Murray PI, Pavesio CE, Gormley PD, Masters J, Parker SP, Stanford MR 1999. Incidence of symptomatic Toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 123: 283-289.
15. Gilbert RE, Stanford MR 2000. Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 84: 224-226.
16. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier M Jr, Silveira S, Camargo ME, Nussenblatt RB, Kaslow RA, Belfort R Jr 1992. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 114: 136-144.
17. Grubeck-Loebenstein B, Wick G 2002. The aging of the immune system. Adv Immunol 80: 243-284.
18. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, Abroms I, Pasternack MS, Hoff R, Eaton RB, Grady GF, New England Regional Toxoplasma Working Group 1994. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 330: 1858-1863.
19. Hogan MJ, Kimura SJ, O'Connor GR 1964. Ocular toxoplasmosis. Arch Ophthalmol 72: 592-600.
20. Holland GN 1999. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 128: 502-505.
21. Holland GN 2003. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 136: 973-988.
22. Holland GN 2004. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 137: 1-17.
23. Holland GN, Crespi CM, ten Dam-van Loon N, Charonis AC, Yu F, Bosch-Driessen LH, Rothova A 2008. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol 145: 1007-1013.
24. Holland GN, Muccioli C, Silveira C, Weisz JM, Belfort R, O'Connor GR 1999. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis. Am J Ophthalmol 128: 413-420.
25. Jankû J 1923. Pathogensa a pathologica anatomie T. Zv. Vrozaneho kolobou zlute skurney oku normal ne velikem a mikrophtalmickem s nalezem parisitu v sitnici. Cas Lek Ses 62: 1021-1027.
26. Johnson MW, Greven GM, Jaffe GJ, Sudhalkar H, Vine AK 1997. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104: 48-57.
27. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB 2001. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154: 357-365.
28. Kimball AC, Kean BH, Fuchs F 1971. Congenital toxoplasmosis: a prospective study of 4,048 obstetric patients. Am J Obstet Gynecol 111: 211-218.
29. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H 1986. Results of 20-year follow-up of congenital toxoplasmosis. Lancet 1: 254-256.
30. Labalette P, Delhaes L, Margaron F, Fortier B, Rouland JF 2002. Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol 133: 506-515.
31. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W, Remington J, Meier P, Johnson D, Heydeman P, Holfels E, Withers S, Mack D, Brown C, Patton D, McLeod R 1994. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial. Clin Infect Dis 18: 38-72.
32. Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L, Stein M, Hopkins J, Withers S, Mack D, Luciano R, Patel D, Remington JS, Meier P, McLeod R 1996. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122: 309-324.
33. Montoya JG, Remington JS 1996. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 23: 277-282.
34. Moshfeghi DM, Dodds EM, Couto CA, Santos CI, Nicholson DH, Lowder CY, Davis JL 2004. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 111: 716-725.
35. Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A, Rothova A 1999. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol 128: 407-412.
36. Papoz L, Simondon F, Saurin W, Sarmini H 1986. A simple model relevant to toxoplasmosis applied to epidemiologic results in France. Am J Epidemiol 123: 154-161.
37. Pawelec G, Solana R, Remarque E, Mariani E 1998. Impact of aging on innate immunity. J Leukoc Biol 64: 703-712.
38. Portela RW, Bethony J, Costa MI, Gazzinelli A, Vitor RW, Hermeto FM, Correa-Oliveira R, Gazzinelli RT 2004. A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A. J Infect Dis 190: 175-183.
39. Rieger H 1951. Zur Klinik der im Erwachsenenalter erworbenen Toxoplasmose. Klin Monatsbl Augenh 119: 459-476.
40. Ronday MJ, Luyendijk L, Baarsma GS, Bollemeijer JG, Van der Lelij A, Rothova A 1995. Presumed acquired ocular toxoplasmosis. Arch Ophthalmol 113: 1524-1529.
41. Silveira C, Belfort R Jr, Burnier MJ, Nussenblatt R 1988. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 106: 362-364.
42. Silveira C, Belfort R Jr, Muccioli C, Abreu MT, Martins MC, Victora C, Nussenblatt RB, Holland GN 2001. A follow-up study of Toxoplasma gondii infection in Southern Brazil. Am J Ophthalmol 131: 351-354.
43. Silveira C, Belfort R Jr, Muccioli C, Holland GN, Victora CG, Horta BL, Yu F, Nussenblatt RB 2002. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134: 41-46.
44. Sousa OE, Saenz RE, Frenkel JK 1988. Toxoplasmosis in Panama: a 10-year study. Am J Trop Med Hyg 38: 315-322.
45. Stagno S, Dykes AC, Amos CS, Head RA, Juranek DD, Walls K 1980. An outbreak of toxoplasmosis linked to cats. Pediatrics 65: 706-712.
46. Stagno S, Reynolds DW, Amos CS, Dahle AJ, McCollister FP, Mohindra I, Ermocilla R, Alford CA 1977. Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics 59: 669-678.
47. Stagno S, Thiermann E 1973. Acquisition of toxoplasma infection by children in a developing country. Bull World Health Organ 49: 627-631.
48. Wilder HC 1952. Toxoplasma chorioretinitis in adults. Arch Ophthalmol 48: 127-136.
49. Wilson CB, Remington JS, Stagno S, Reynolds DW 1980. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 66: 767-774.
50. Wising P 1952. Akut adult toxoplasmos med lymfadenopathi och chorioretinit. Nord Med 47: 563-565.
51. Wolf A, Cowen D, Paige BH 1939. Human toxoplasmosis: occurence in infants as an encephalomyelitis; verification by transmission to animals. Science 89: 226-227.
52. Yang P, Das PK, Kijlstra A 2000. Localization and characterization of immunocompetent cells in the human retina. Ocul Immunol Inflamm 8:149-157.